Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

GBP/USD Daily Forecast – UK Retail Sales Slumps, BoE Up Next

GBP/USD is trading in a tight range just above the 1.3100 level but volatility is expected as the Bank of England announces their latest rate decision later in the day. Jignesh Davda UK Retail Sales Decline ...
FX Empire | December 20, 2019 |

Surprise decision in the UK to thwart a No-Deal Brexit changed the dynamics of the markets

Our August 19 th prediction of a market breakdown, as well as our continued research suggesting a breakdown in price was the most likely outcome, is a combination of technical analysis, predictive modeling and our understanding of the market dynamics at play throughout the wo...
Chris Vermeulen | September 5, 2019 |

The U.K. Just Said No to EU Socialism. Will U.S. Voters Do the Same in 2020?

Let’s begin with a thought experiment. Imagine you wake up tomorrow from a three and a half-year coma. Everything that’s happened in the meantime—the election of Donald Trump, impeachment, Brexit and more—is a complete mystery to you....
Frank Holmes | December 23, 2019 |

Important Economic News Calendar: October 14 – October 18, 2019

The markets basically ignored the Fed talk last week, as U.S. - China trade war developments stole investors’ attention away from the scheduled news releases. But it was worth paying attention to our last week’s News Calendar that highlighted U....
Paul Rejczak | October 15, 2019 |

Market News Report: December 16 – December 20, 2019

The markets were pretty quiet early last week ahead of Wednesday’s FOMC Rate Decision announcement. But it didn’t move them that much. All changed on Thursday following Donald Trump’s tweet about the coming trade deal. It set the...
Paul Rejczak | December 17, 2019 |

i3 Energy building oil and gas assets

With much of Europe gripped in an oil and gas supply crisis, i3 Energy remains focused on the acquisition, development, and production of long-life, low-decline, high-return assets. The company is anchored in Canada and the United Kingdom, with assets in Western Canada&Cl...
Simon Druker | May 11, 2023 |

Psyence Group: natural psychedelics for mental health and wellbeing

Our next company works to help people with a focus on natural psychedelics. Psyence Group uses natural psilocybin products to heal psychological trauma and to calm the mind during someone’s last stage of life while in palliative care. Here with us toda...
Brieanna McCutcheon | March 2, 2023 |

Important Economic News Calendar: November 4 – November 8, 2019

The markets will likely take some breather in the coming week following last week’s huge economic data announcements. But that does not mean there won’t be trading opportunities coming from the data releases. Last week we asked if quarterly corp...
Paul Rejczak | November 4, 2019 |

The Duel Between Johnson and Parliament. Will Gold Win?

Boris Johnson struggles to push the Brexit agreement through the British Parliament. For it can bite back! Who wins this battle? One could hope that gold, but this is not so certain… Johnson’s Struggle, Explained On Thursday, the breaking news came ...
Arkadiusz Sieron | October 23, 2019 |

Trial Milestone Reached; U.K.-Based Biopharma Gets $15 Million

The first patient has been treated in the second cohort of a Phase 2 study of a gene therapy targeting Parkinson's disease, explained an H.C. Wainwright & Co. report. In an April 30 research note, analyst Joseph Pantginis reported that Oxford Biomedica Plc ...
Streetwise Reports | May 9, 2019 |
1 2 3 4 5 6 7 8 9 10 ...